NON MUSCLE INVASIVE BLADDER CANCER
Clinical trials for NON MUSCLE INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new NON MUSCLE INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for NON MUSCLE INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bladder cancer patients: drug combo targets tough cases
Disease control Not yet recruitingThis study tests a combination of two chemotherapy drugs placed directly into the bladder plus an immunotherapy drug given through a vein. It is for people with high-risk non-muscle invasive bladder cancer that did not respond to or could not receive standard BCG therapy. The goa…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: BLATAM • Aim: Disease control
Last updated May 17, 2026 03:31 UTC
-
Heated chemo offers new hope for bladder cancer patients avoiding surgery
Disease control Not yet recruitingThis study tests a treatment called HIVEC, which delivers heated chemotherapy directly into the bladder. It is for people with high-grade bladder cancer that has not spread into the muscle wall, but who cannot have or refuse bladder removal surgery. The goal is to see if this app…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: NA • Sponsor: AC.TA. S.r.l. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New injection method during bladder surgery aims to slash cancer recurrence
Disease control Not yet recruitingThis study tests if injecting the chemotherapy drug gemcitabine directly into the bladder wall during tumor removal surgery can prevent intermediate- and high-risk non-muscle-invasive bladder cancer from coming back. About 320 adults aged 18-80 will take part. The goal is to see …
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE2, PHASE3 • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
New drug combo aims to spare bladders from surgery
Disease control Not yet recruitingThis study is for people with a high-risk form of bladder cancer that has not responded to or cannot tolerate the standard BCG treatment. It compares a two-part treatment—an immunotherapy drug given through a vein plus a two-drug chemotherapy wash placed directly into the bladder…
Matched conditions: NON MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC